Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented ...

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

Cryo-EM structure of the human adenosine A1 receptor (A1R, white) in complex with the orthosteric agonist adenosine (magenta) ...

A burning sensation in the feet is usually harmless and temporary; however if it is chronic it can be due to various ...

Neuros Medical announced today that it closed an oversubscribed Series D financing round worth $56 million in proceeds.

The FDA has granted de novo marketing authorisation to TISSIUM’s COAPTIUM CONNECT, representing the first atraumatic option for repairing peripheral nerve damage.

Tissium announced today that it received FDA de novo marketing authorization for Coaptium Connect with Tissium Light.

THE WOODLANDS, Texas, June 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that data from a study evaluating the impact of sotagliflozin on hypoglycemia in people ...